COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,284 Articles (22,759 medRxiv, 8,525 bioRxiv)

Most recent first Previous |  Page 2836: Articles 28351-28360  | Next

Repeated seroprevalence of anti-SARS-CoV-2 IgG antibodies in a population-based sample from Geneva, Switzerland
Stringhini, S., Wisniak, A., Piumatti, G., Azman, A. S., Lauer, S. A., Baysson, H., De Ridder, D., Petrovic, D., Schrempft, S., Marcus, K., Arm-Vernez, I., Yerly, S., Keiser, O., Hurst, S., Posfay-Barbe, K., Trono, D., Pittet, D., Getaz, L., Chappuis, F., Eckerle, I., Vuilleumier, N., Meyer, B., Flahault, A., Kaiser, L., Guessous, I.
10.1101/2020.05.02.20088898 — Posted: 2020-05-06 Discussion: Onsite
Evaluation of nCoV-QS (MiCo BioMed) for RT-qPCR detection of SARS-CoV-2 from nasopharyngeal samples using CDC FDA EUA qPCR kit as a gold standard: an example of the need of validation studies.
Freire-Paspuel, B., Vega, P., Velez, A., Castello, P., Cruz, M., Garcia Bereguiain, M. A.
10.1101/2020.05.01.20081034 — Posted: 2020-05-06 Discussion: Onsite
FACTORS INFLUENCING MENTAL HEALTH DURING COVID-19 OUTBREAK: AN EXPLORATORY SURVEY AMONG INDIAN POPULATION
Ahmad, A., Rahman, I., Agarwal, M.
10.1101/2020.05.03.20081380 — Posted: 2020-05-06
SARS-CoV-2 codon usage bias downregulates host expressed genes with similar codon usage
Alonso, A. M., Diambra, L.
10.1101/2020.05.05.079087 — Posted: 2020-05-06 Discussion: Onsite
Repurposing low-molecular-weight drugs against the main protease of SARS-CoV-2
Gao, J., Zhang, L., Liu, X., Li, F., Ma, R., Zhu, Z., Zhang, J., Wu, J., Shi, Y., Pan, Y., Ge, Y., Ruan, K.
10.1101/2020.05.05.079848 — Posted: 2020-05-06
Unsupervised cluster analysis of SARS-CoV-2 genomes reflects its geographic progression and identifies distinct genetic subgroups of SARS-CoV-2 virus
Hahn, G., Lee, S., Weiss, S., Lange, C.
10.1101/2020.05.05.079061 — Posted: 2020-05-06
Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and their implications
Chand, G. B., Azad, G. K.
10.1101/2020.05.05.079939 — Posted: 2020-05-06
Coronavirus activates a stem cell-mediated defense mechanism that accelerates the activation of dormant tuberculosis: implications for the COVID-19 pandemic
Pathak, L., Gayan, S., Pal, B., Talukdar, J., Bhuyan, S., Sandhya, S., Yeger, H., Baishya, D., Das, B.
10.1101/2020.05.06.077883 — Posted: 2020-05-06 Discussion: Onsite | Offsite
Development and simulation of fully glycosylated molecular models of ACE2-Fc fusion proteins and their interaction with the SARS-CoV-2 spike protein binding domain
Bernardi, A., Huang, Y., Xiong, Y., Nandi, S., McDonald, K. A., Faller, R.
10.1101/2020.05.05.079558 — Posted: 2020-05-06
Applying Lexical Link Analysis to DiscoverInsights from Public Information on COVID-19
Zhao, Y., Zhou, C. C.
10.1101/2020.05.06.079798 — Posted: 2020-05-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).